Journal of International Psychiatry

Objective: To study the effects of risperidone combined cognitive-behavioral therapy on PANSS score and quality of life in patients with residual symptoms of schizophrenia. Methods: Randomly selected from our hospital from January 2014 to January 2014 in admitted during the period of 60 cases of schizophrenia patients with type residual symptoms as the research object, and it can be divided into observation group and control group, the control group were treated by routine drug risperdal treatment, observation group of patients on the basis of risperidone treatment increase cognitive behavioral therapy, two groups of treatment effect observed, changes of the PANSS score and life quality. Results: After treatment, the observation group of patients with PANSS score and negative symptom scores were significantly lower than control group (P < 0.05), the observation group of patients quality of life score is significantly higher than control group (P < 0.05), and the observation group of patients with SAS and SDS score compared with the control group with statistical significance (P < 0.05). Conclusion: Risperidone combined cognitive behavioral therapy type schizophrenia residual symptoms of clinical effect is remarkable, can effectively improve the negative symptoms and anxiety, help to improve the quality of life of patients.

Key words: Risperidone; Cognitive behavioral therapy; Schizophrenia